Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis
Crossref DOI link: https://doi.org/10.1007/s10753-015-0193-2
Published Online: 2015-06-06
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Yun-Fang
Zou, Xun-Liang
WU, Jun
Yu, Xue-Qing
Yang, Xiao
Text and Data Mining valid from 2015-06-06